Hi, what are you looking for?
Top-performing hedge fund manager Larry Robbins on Dec. 10 increased his holdings in Avis Budget Group Inc., PVH Corp and Lithia Motors Inc., value...
Israeli Arabs are also getting in on the successes of startup nation. Doctor Amal Ayoub is the founder and CEO of Metallo-Therapy which has...
Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, treated the first patient with...
– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. – Medivation has decided to exercise the option...
– Sydney: Despite a worldwide obsession with diets and fitness regimes, many health professionals cannot correctly answer the question of where body fat...
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
Researchers at the Ben Gurion University in Beer Sheva have made a major breakthrough in the study of molecular biology. They have discovered the...
NYU economist Nouriel Roubini says there is more pain ahead. He thinks the stock market is headed toward the “mother of all asset bubbles,...
On CNBC’s Mad Money, Cramer talked about sector rotation, or when investors move from preferring one group of stocks to another. The stock that...
Jim Cramer discussed his stock picks on CNBC’s Mad Dash segment. Cramer said Fed Chief Janet Yellen made the worst stock call he has...